Advanced search
Publication Cover
Aging Health Volume 9, 2013 - Issue 2
Journal homepage
48
Views
0
CrossRef citations to date
0
Altmetric
Theme: Cardiovascular Disease - Research Article

Comparison of Cardiac Amyloidosis Due to Wild-Type and V122I Transthyretin in Older Adults Referred to an Academic Medical Center

Raymond C Givens1 Clinical Cardiovascular Research Laboratory for the Elderly, Center for Advanced Cardiac Care, Division of Cardiology, Columbia College of Physicians & Surgeons, 622 West 168th Street, PH 12-1291, NY, USAView further author information
,
Chris Russo1 Clinical Cardiovascular Research Laboratory for the Elderly, Center for Advanced Cardiac Care, Division of Cardiology, Columbia College of Physicians & Surgeons, 622 West 168th Street, PH 12-1291, NY, USAView further author information
,
Philip Green1 Clinical Cardiovascular Research Laboratory for the Elderly, Center for Advanced Cardiac Care, Division of Cardiology, Columbia College of Physicians & Surgeons, 622 West 168th Street, PH 12-1291, NY, USAView further author information
&
Mathew S Maurer1 Clinical Cardiovascular Research Laboratory for the Elderly, Center for Advanced Cardiac Care, Division of Cardiology, Columbia College of Physicians & Surgeons, 622 West 168th Street, PH 12-1291, NY, USA. [email protected].Correspondence[email protected]
View further author information
Pages 229-235 | Published online: 04 Apr 2013

References

  • Dharmarajan K , MaurerMS. Transthyretin cardiac amyloidoses in older North Americans. J. Am. Geriatr. Soc.60, 765–774(2012).
  • Ruberg FL , BerkJL. Transthyretin (TTR) cardiac amyloidosis. Circulation126, 1286–1300(2012).
  • Lai Z , ColonW, KellyJW. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry35, 6470–6482(1996).
  • Jacobson DR , PastoreR, PoolSet al. Revised transthyretin Ile 122 allele frequency in African–Americans. Hum. Genet. 98, 236–238(1996).
  • Yamashita T , Hamidi Asl K, Yazaki M, Benson MD. A prospective evaluation of the transthyretin Ile122 allele frequency in an African–American population. Amyloid12, 127–130(2005).
  • Jiang X , BuxbaumJN, KellyJW. The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis. Proc. Natl Acad. Sci. USA98, 14943–14948(2001).
  • Buck FS , KossMN, SherrodAE, WuA, TakahashiM. Ethnic distribution of amyloidosis: an autopsy study. Mod. Pathol.2, 372–377(1989).
  • Dungu J , SattianayagamPT, WhelanCJet al. The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro–Caribbean patients. Am. Heart J. 164, 72–79(2012).
  • Jacobson D , TagoeC, SchwartzbardA, ShahA, KoziolJ, BuxbaumJ. Relation of clinical, echocardiographic and electrocardiographic features of cardiac amyloidosis to the presence of the transthyretin V122I allele in older African–American men. Am. J. Cardiol.108, 440–444(2011).
  • Connors LH , ProkaevaT, LimAet al. Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. Am. Heart J. 158, 607–614(2009).
  • Buxbaum J , AlexanderA, KoziolJ, TagoeC, FoxE, KitzmanD. Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies. Am. Heart J.159, 864–870(2010).
  • Ruberg FL , MaurerMS, JudgeDPet al. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS). Am. Heart J. 164, 222–228.e1 (2012).
  • Bulawa CE , ConnellyS, DevitMet al. Tafamid is, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc. Natl Acad. Sci. USA 109, 9629–9634(2012).
  • de Lartigue J . Tafamidis for transthyretin amyloidosis. Drugs Today48, 331–337(2012).
  • Castano A , HelmkeS, AlvarezJ, DelisleS, MaurerMS. Diflunisal for ATTR cardiac amyloidosis. Congest. Heart Fail.18(6), 315–319(2012).
  • Ackermann EJ , GuoS, BootenSet al. Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy. Amyloid 19(Suppl. 1), 43–44(2012).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.